Therefore, this systematic review and network meta-analysis was performed to investigate the comparative efficacy and safety of the four GLP-1 RAs in children and adolescents with obesity or overweight. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.